Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Sales Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Net Sales Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Net Sales Growth(%) 9.3916.685.97-5.327.26

What is the latest Net Sales Growth ratio of AUROBINDO PHARMA ?

The latest Net Sales Growth ratio of AUROBINDO PHARMA is 9.39 based on Mar2025 Consolidated results.
Year Net Sales Growth
Mar20259.39
Mar202416.68
Mar20235.97
Mar2022-5.32
Mar20217.26

How is Net Sales Growth of AUROBINDO PHARMA Trending?

Years Net Sales Growth % Change
Mar2025 9.39
-43.71
Mar2024 16.68
179.40
Mar2023 5.97
Positive
Mar2022 -5.32
Negative
Mar2021 7.26 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Net Sales Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹77,806.9 Cr 0.8% 4.2% 22.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.8%

4.2%

22.2%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses